Roche Keeps Muted Outlook as Sales Fall
Wall Street Journal
Roche reiterated its financial outlook for 2023 after it reported a 6% fall in revenue for the first nine months, with growth in its pharmaceutical division overshadowed by a sharp drop in diagnostics sales due to weaker Covid-19-related demand.
https://www.wsj.com/articles/roche-backs-guidance-after-sales-fall-f6e984e5